Phone:0086-13810583161
4
banner3
banner1

product

Focus on medical equipment for 27 years

more>>

about us

About factory description

about_us

what we do

Founded in 1994, Beijing KellyMed Co., Ltd. is a high technology corporation engaged in R&D, manufacturing and marketing of infusion systems, supported by Institute of Mechanics, Chinese Academy of Sciences. Manufacturing Facility, R&D Center, QC Division, Domestic Sales Division, Int’l Sales Division and Customer Support Center were established under KellyMed. Engineers are major in Physics, Infrared Radiation, Electronics, Ultrasound, Automation, Computer, Sensor and Mechanics.

more>>
learn more

Our newsletters, the latest information about our products, news and special offers.

Click for manual
  • New technology transformation mode,research high quality products

    technology

    New technology transformation mode,research high quality products

  • Professional research project team for different customer needs

    Research

    Professional research project team for different customer needs

  • The company introduces a large number of talents, researches projects and is responsible for customers

    personnel

    The company introduces a large number of talents, researches projects and is responsible for customers

application

Lorem ipsum dolor sit amet, consectetur adipisicing elit

  • ICU

  • NICU

  • Operation Room

  • Nursing Home

  • 30 30

    Years In Medical

  • 400+ 400+

    Kellymed Staff

  • 60+ 60+

    Countries

  • 50000 50000

    Installations

  • 100+ 100+

    Overseas Distributors

news

Lorem ipsum dolor sit amet, consectetur adipisicing elit

News Center

Global medical device industry information

Infusion Pump at Expomed 2023

        This website is operated by one or more companies owned by Informa PLC and all copyrights are held by them. The registered office of Informa PLC is at 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.        The ke...
more>>

Global Market for Bone Growth Stimulants to Rea...

        VANCOUVER, BC, Feb. 22, 2023 /PRNewswire/ — The global bone growth stimulant market is valued at $2.22 billion in 2022 and is expected to grow at a CAGR of 5.5% over the forecast period . emerging research. Revenue growth in the bone growth stimulants market is...
more>>